Free Account Opening + AMC Free Demat
Loading...

Jenburkt Pharmaceuticals Buyback vs KAMA Holdings Buyback

Comparision between Jenburkt Pharmaceuticals Buyback and KAMA Holdings Buyback.

Buyback Details

Jenburkt Pharmaceuticals Buyback is a Open Market Through Stock Exchange buyback proposed to list at BSE while KAMA Holdings Buyback is a Tender Offer proposed to list at BSE.

  Jenburkt Pharmaceuticals Ltd KAMA Holdings Limited
Logo Jenburkt Pharmaceuticals Buyback Logo KAMA Holdings Buyback Logo
Type of Buyback Open Market Through Stock Exchange Tender Offer
Listing At BSE BSE
Face Value ₹10 per share ₹10 per share
Buyback Price ₹702 per share ₹14500 per share
Issue Size 34,500 shares
Issue Size (Amount) ₹11.60 Crores ₹50.03 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders15 Equity Shares out of every 47 Fully paid-up Equity Shares held on the Record Date.5,175.00
General Category for all other Eligible Shareholders2 Equity Shares out of every 439 Fully paid-up Equity Shares held on the Record Date.29,325.00
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Lead Managers Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) SBI Capital Markets Limited
Necessity of the buyback

The buyback is being undertaken for the following reason:

  • The company is expected to achieve the objective of returning surplus funds to the shareholders, improving return on equity through distribution of surplus funds, improving earnings per share by reduction in equity base and increasing shareholders' value in the long term by improving key return ratios.
  • The Buyback will lead to reduction in outstanding Equity Shares of the Company, improvement in 'earnings per share' and enhanced return on equity.

The Buyback is being proposed by the company for the following benefits:

  1. The Buyback will improve financial ratios like earnings per share, return on capital employed, and return on equity, calculated based on financial statements, by a reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.
  2. The Buyback will help in achieving an optimal capital structure.
  3. The Buyback gives an option to the Eligible Shareholders to either (i) choose to participate and get cash instead of Equity Shares to be accepted under the Buyback or (ii) choose to not participate and enjoy a resultant increase in their percentage shareholding, post Buyback, without additional investment.

Buyback Timetable

Jenburkt Pharmaceuticals Buyback and KAMA Holdings Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Jenburkt Pharmaceuticals Buyback Buyback record date is . KAMA Holdings Buyback Buyback record date is Dec 23, 2022.

  Jenburkt Pharmaceuticals Ltd KAMA Holdings Limited
Record Date Dec 23, 2022
Offer Open Date Dec 14, 2022 Jan 31, 2023
Offer Closure Date Mar 24, 2023 Feb 13, 2023
Last date for receipt of tender forms Feb 13, 2023
Finalisation of buyback Feb 21, 2023
Last Date for settlment of bids Feb 22, 2023
Last Date for extinguishment of shares Mar 01, 2023

Financial Details and Other Relevent Information

Comparison of Jenburkt Pharmaceuticals Buyback and KAMA Holdings Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Jenburkt Pharmaceuticals Ltd KAMA Holdings Limited
Financial
Jenburkt Pharmaceuticals Ltd Financial Information (Restated)
Period EndedTotal RevenueProfit After TaxNet WorthTotal Borrowing
31-Mar-20123.1114.8782.345.18
31-Mar-21113.616.598.855.07
31-Mar-22128.9322.3116.466.76
Amount in ₹ Crore
KAMA Holdings Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-2113280.798499.911196.62
31-Mar-2216210.5312588.241888.86
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2022 645.15 572.00 590.12
Oct-2022 577.25 548.65 563.91
Sep-2022 605.95 535.70 581.48

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2022 13997.50 12085.25 13053.04
Oct-2022 13566.90 12353.05 12859.01
Sep-2022 14600.00 12250.05 13113.94
Stock price at NSE

Comments

Add a public comment...